These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20231393)

  • 21. Plasmid-encoded OXA-48 carbapenemase in Escherichia coli from Israel.
    Goren MG; Chmelnitsky I; Carmeli Y; Navon-Venezia S
    J Antimicrob Chemother; 2011 Mar; 66(3):672-3. PubMed ID: 21177669
    [No Abstract]   [Full Text] [Related]  

  • 22. Multiple ST clonal complexes, with a predominance of ST131, of Escherichia coli harbouring blaCTX-M-15 in a tertiary hospital in Tanzania.
    Mshana SE; Imirzalioglu C; Hain T; Domann E; Lyamuya EF; Chakraborty T
    Clin Microbiol Infect; 2011 Aug; 17(8):1279-82. PubMed ID: 21595794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and characterisation of CTX-M β-lactamases amongst Escherichia coli isolates from healthy food animals in China.
    Zheng H; Zeng Z; Chen S; Liu Y; Yao Q; Deng Y; Chen X; Lv L; Zhuo C; Chen Z; Liu JH
    Int J Antimicrob Agents; 2012 Apr; 39(4):305-10. PubMed ID: 22325120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High presence of extended-spectrum beta-lactamases and resistance to quinolones in clinical isolates of Escherichia coli.
    Sorlózano A; Gutiérrez J; de Dios Luna J; Oteo J; Liébana J; Soto MJ; Piédrola G
    Microbiol Res; 2007; 162(4):347-54. PubMed ID: 16564161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of Escherichia coli ST131 producing KPC-2 in Bulgaria.
    Markovska R; Stoeva T; Boyanova L; Stankova P; Pencheva D; Kaneva R; Mitev V; Mitov I
    Infect Dis (Lond); 2017 May; 49(5):429-431. PubMed ID: 28049378
    [No Abstract]   [Full Text] [Related]  

  • 26. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada.
    Boyd DA; Tyler S; Christianson S; McGeer A; Muller MP; Willey BM; Bryce E; Gardam M; Nordmann P; Mulvey MR
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3758-64. PubMed ID: 15388431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
    Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
    J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
    Briñas L; Lantero M; de Diego I; Alvarez M; Zarazaga M; Torres C
    J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of bla(CMY-7) and associated plasmid-mediated resistance genes in multidrug-resistant Escherichia coli isolated from dogs at a veterinary teaching hospital in Australia.
    Sidjabat HE; Townsend KM; Hanson ND; Bell JM; Stokes HW; Gobius KS; Moss SM; Trott DJ
    J Antimicrob Chemother; 2006 May; 57(5):840-8. PubMed ID: 16524894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbapenem resistance due to Bla(OXA-48) among ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates in a univesity hospital, Turkey.
    Nazik H; Ongen B; Ilktac M; Aydin S; Kuvat N; Sahin A; Yemisen M; Mete B; Durmus MS; Balkan II; Yildiz I; Ergul Y
    Southeast Asian J Trop Med Public Health; 2012 Sep; 43(5):1178-85. PubMed ID: 23431824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered at two Belgian hospitals.
    Bogaerts P; Rodriguez-Villalobos H; Bauraing C; Deplano A; Laurent C; Berhin C; Struelens MJ; Glupczynski Y
    Pathol Biol (Paris); 2010 Feb; 58(1):78-83. PubMed ID: 19892478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterization of Carbapenem resistant Escherichia coli recovered from a tertiary hospital in Lebanon.
    Dagher C; Salloum T; Alousi S; Arabaghian H; Araj GF; Tokajian S
    PLoS One; 2018; 13(9):e0203323. PubMed ID: 30188911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Updated molecular epidemiology of carbapenem-non-susceptible Escherichia coli in Taiwan: first identification of KPC-2 or NDM-1-producing E. coli in Taiwan.
    Ma L; Siu LK; Lin JC; Wu TL; Fung CP; Wang JT; Lu PL; Chuang YC
    BMC Infect Dis; 2013 Dec; 13():599. PubMed ID: 24354657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of extended-spectrum beta-lactamase and class 1 integron integrase gene intl1 in Escherichia coli from Thai patients and healthy adults.
    Pongpech P; Naenna P; Taipobsakul Y; Tribuddharat C; Srifuengfung S
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):425-33. PubMed ID: 18564681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
    Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
    J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China.
    Qi Y; Wei Z; Ji S; Du X; Shen P; Yu Y
    J Antimicrob Chemother; 2011 Feb; 66(2):307-12. PubMed ID: 21131324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Features of infections due to Klebsiella pneumoniae carbapenemase-producing Escherichia coli: emergence of sequence type 131.
    Kim YA; Qureshi ZA; Adams-Haduch JM; Park YS; Shutt KA; Doi Y
    Clin Infect Dis; 2012 Jul; 55(2):224-31. PubMed ID: 22491340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of acquired β-lactamases on the evolution of spontaneous carbapenem resistance in Escherichia coli.
    Adler M; Anjum M; Andersson DI; Sandegren L
    J Antimicrob Chemother; 2013 Jan; 68(1):51-9. PubMed ID: 22977158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of Escherichia coli ST131 sub-clone H30 producing VIM-1 and KPC-3 carbapenemases, Italy.
    Accogli M; Giani T; Monaco M; Giufrè M; García-Fernández A; Conte V; D'Ancona F; Pantosti A; Rossolini GM; Cerquetti M
    J Antimicrob Chemother; 2014 Aug; 69(8):2293-6. PubMed ID: 24797065
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of Carbapenem-Resistant Escherichia coli Isolates Through the Whole-Genome Sequencing Analysis.
    Luo Y; Luo R; Ding H; Ren X; Luo H; Zhang Y; Ye L; Cui S
    Microb Drug Resist; 2018 Mar; 24(2):175-180. PubMed ID: 28686503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.